1
|
Bendi A, Yadav P, Saini K, Singh Bhathiwal A, Raghav N. A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity. Chem Biodivers 2024; 21:e202400067. [PMID: 38500408 DOI: 10.1002/cbdv.202400067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 03/18/2024] [Accepted: 03/18/2024] [Indexed: 03/20/2024]
Abstract
Tuberculosis is a communicable disease which affects humans particularly the lungs and is transmitted mainly through air. Despite two decades of intensive research aimed at understanding and combating tuberculosis, persistent biological uncertainties continue to hinder progress. Nowadays, heterocyclic compounds have proven themselves in effective treatment of tuberculosis because of their wide range of biological and pharmacological activities. Antituberculosis or antimycobacterial agents encompass a broad array of compounds utilized singly or in conjunction to combat Mycobacterium infections, spanning from tuberculosis to leprosy. Here, we summarize the synthesis of various heterocyclic compounds which includes the greener synthetic route as well as use of nano compounds as catalyst along with their anti TB activities.
Collapse
Affiliation(s)
- Anjaneyulu Bendi
- Department of Chemistry, Presidency University, Rajanukunte, Itgalpura, 560064, Bangalore, India
| | - Priyanka Yadav
- Department of Chemistry, Faculty of Science, SGT University, 122505, Gurugram, Haryana, India
| | - Komal Saini
- Applied Sciences and Humanities, World College of Technology and Management, 122506, Gurugram, Haryana, India
| | - Anirudh Singh Bhathiwal
- Department of Chemistry, Faculty of Science, SGT University, 122505, Gurugram, Haryana, India
| | - Neera Raghav
- Department of Chemistry, Kurukshetra University, 136119, Kurukshetra, Haryana, India
| |
Collapse
|
2
|
Dwarakanath D, Gaonkar SL. Advances in Synthetic Strategies and Medicinal Importance of Benzofurans: A Review. ASIAN J ORG CHEM 2022. [DOI: 10.1002/ajoc.202200282] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Deepika Dwarakanath
- Department of Chemistry Manipal Institute of Technology Manipal Academy of Higher Education 576104 Manipal Karnataka India
| | - Santosh L. Gaonkar
- Department of Chemistry Manipal Institute of Technology Manipal Academy of Higher Education 576104 Manipal Karnataka India
| |
Collapse
|
3
|
Sartaj A, Annu, Alam M, Biswas L, Yar MS, Mir SR, Verma AK, Baboota S, Ali J. Combinatorial delivery of Ribociclib and Green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronizing in silico, in vitro, and in vivo studies. J Drug Target 2022; 30:1113-1134. [PMID: 35856926 DOI: 10.1080/1061186x.2022.2104292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Purpose: The current research investigated the development and evaluation of dual drug-loaded nanostructure lipidic carriers (NLCs) of green tea extract and Ribociclib.Method: In silico study were performed to determine the effectiveness of combinational approach. The prepared NLCs were subjected to in vitro drug release, lipolysis, haemolysis and cell line studies to assess their in vivo prospect.Results: In silico study was done to get docking score of EGCG (-8.98) close to Ribociclib (-10.78) in CDK-4 receptors. The prepared NLCs exhibited particle size (175.80 ± 3.51 nm); PDI (0.571 ± 0.012); and %EE [RBO (80.91 ± 1.66%) and GTE 75.98 ± 2.35%)] respectively. MCF-7 cell lines were used to evaluate the MTT assay, cellular uptake and antioxidant (ROS and SOD) of prepared NLCs. In vitro drug release showed the controlled release up to 72 h. In vitro lipolysis and in vitro haemolysis studies showed the availability of drugs at absorption sites and the greater in vivo prospects of NLCs respectively. Pharmacokinetic study revealed a 3.63-fold and 1.53-fold increment in RBO and GTE bioavailability in female Wistar rats respectively.Conclusion: The prominent potential of green tea extract and RBO-loaded NLCs in enhancing their therapeutic efficacy for better treatment of breast cancer.
Collapse
Affiliation(s)
- Ali Sartaj
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| | - Annu
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| | - Meraj Alam
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| | - Largee Biswas
- Nanobiotech Lab, Kirori Mal College, University of Delhi, Delhi, 110007, India
| | - Mohammad Shahar Yar
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| | - Showkat Rasool Mir
- Department of Pharmacognosy and Phytochemistry, Phytomedicine Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| | - Anita Kamra Verma
- Nanobiotech Lab, Kirori Mal College, University of Delhi, Delhi, 110007, India
| | - Sanjula Baboota
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| | - Javed Ali
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
| |
Collapse
|